MetLife Investment Management, LLC - CYTOMX THERAPEUTICS INC ownership

CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 129 filers reported holding CYTOMX THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of CYTOMX THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$47,238
-55.4%
17,692
-27.6%
0.00%
-100.0%
Q4 2021$105,851
+110.5%
24,446
+147.4%
0.00%
Q3 2021$50,289
-69.6%
9,880
-62.2%
0.00%
-100.0%
Q2 2021$165,264
+306.3%
26,108
+396.2%
0.00%
Q1 2021$40,675
-58.7%
5,262
-65.0%
0.00%
-100.0%
Q4 2020$98,420
-1.5%
15,0260.0%0.00%0.0%
Q3 2020$99,923
-56.1%
15,026
-45.0%
0.00%
-66.7%
Q2 2020$227,426
+8.6%
27,3020.0%0.00%0.0%
Q1 2020$209,406
-7.7%
27,3020.0%0.00%
+50.0%
Q4 2019$226,880
+12.6%
27,3020.0%0.00%0.0%
Q3 2019$201,489
-34.2%
27,3020.0%0.00%
-33.3%
Q2 2019$306,327
+55.8%
27,302
+49.3%
0.00%
+50.0%
Q1 2019$196,618
-28.8%
18,2900.0%0.00%
-33.3%
Q4 2018$276,179
-18.4%
18,2900.0%0.00%
-25.0%
Q3 2018$338,365
-19.1%
18,2900.0%0.00%
-20.0%
Q2 2018$418,000
+9.1%
18,290
+35.9%
0.01%0.0%
Q1 2018$383,000
+56.3%
13,459
+16.0%
0.01%
+66.7%
Q4 2017$245,00011,5990.00%
Other shareholders
CYTOMX THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
BVF INC/IL 5,576,471$36,526,0001.44%
Altium Capital Management LP 273,703$1,793,0000.67%
Jackson Creek Investment Advisors LLC 80,367$526,0000.21%
HARBOURVEST PARTNERS LLC 79,193$519,0000.20%
XTX MARKETS LLC 14,169$93,0000.19%
Perceptive Advisors 2,577,043$16,880,0000.18%
RTW INVESTMENTS, LP 1,527,352$10,004,0000.17%
Exane Asset Management 30,568$200,220,0000.14%
Virtus ETF Advisers LLC 37,343$245,0000.10%
Congress Park Capital LLC 25,807$169,0000.10%
View complete list of CYTOMX THERAPEUTICS INC shareholders